Call Options

16 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$111.15 - $128.97 $77,805 - $90,279
-700 Reduced 12.07%
5,100 $579,000
Q2 2024

Aug 05, 2024

SELL
$123.8 - $132.96 $420,920 - $452,064
-3,400 Reduced 36.96%
5,800 $718,000
Q1 2024

May 08, 2024

BUY
$113.24 - $131.95 $588,848 - $686,139
5,200 Added 130.0%
9,200 $1.21 Million
Q4 2023

Feb 02, 2024

SELL
$100.18 - $109.02 $130,234 - $141,726
-1,300 Reduced 24.53%
4,000 $436,000
Q3 2023

Oct 26, 2023

SELL
$102.95 - $114.33 $30,885 - $34,299
-300 Reduced 5.36%
5,300 $545,000
Q2 2023

Aug 08, 2023

SELL
$108.61 - $118.38 $152,054 - $165,732
-1,400 Reduced 20.0%
5,600 $646,000
Q1 2023

May 02, 2023

BUY
$102.94 - $114.86 $174,998 - $195,262
1,700 Added 32.08%
7,000 $744,000
Q4 2022

Jan 23, 2023

BUY
$87.44 - $112.11 $463,432 - $594,183
5,300 New
5,300 $0
Q3 2022

Oct 18, 2022

BUY
$84.53 - $94.96 $1.44 Million - $1.61 Million
17,000 New
17,000 $33,000
Q4 2021

Jan 10, 2022

BUY
$72.28 - $90.54 $2.85 Million - $3.57 Million
39,400 Added 133.56%
68,900 $40,000
Q3 2021

Oct 14, 2021

SELL
$71.68 - $78.83 $931,840 - $1.02 Million
-13,000 Reduced 30.59%
29,500 $44,000
Q2 2021

Jul 26, 2021

BUY
$70.31 - $77.77 $2.19 Million - $2.43 Million
31,200 Added 276.11%
42,500 $61,000
Q4 2019

Jan 06, 2020

SELL
$77.58 - $87.54 $395,658 - $446,454
-5,100 Reduced 31.1%
11,300 $29,000
Q3 2019

Oct 03, 2019

BUY
$76.08 - $82.93 $1.25 Million - $1.36 Million
16,400 New
16,400 $19,000
Q2 2019

Jul 10, 2019

SELL
$69.84 - $81.59 $873,000 - $1.02 Million
-12,500 Closed
0 $0
Q4 2018

Jan 03, 2019

BUY
$65.24 - $75.71 $815,499 - $946,374
12,500 New
12,500 $26,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $251B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Xr Securities LLC Portfolio

Follow Xr Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xr Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Xr Securities LLC with notifications on news.